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ABSTRACT 
Stacey Adjei 
HIV Care Retention and Attainment of Viral Suppression among Georgia Women during 
Pregnancy and Postpartum Period 
 
Background: Rates of care retention and maintenance of viral suppression differ by location in 
the Unites States due the varying public health policies and infrastructures. As a result, it is 
imperative to determine the rates of retention and viral suppression as well as factors associated 
with these changes during the prenatal and postpartum period in the state of Georgia 
  
Methods: Data on 161 HIV infected women was collected from birth certificate records and the 
enhanced HIV/AIDS Reporting System (eHARS). Multivariate logistic regression was used to 
determine the association between sociodemographic as well as clinical variables and outcome 
variables of retention, viral suppression and care engagement during and after pregnancy. 
 
 Results:  Women were more likely to be retained in care during pregnancy (79.50%) than 
during the postpartum period (55.28%). Women were also more likely to achieve viral 
suppression during pregnancy (68.94%) than during the postpartum period (49.69%). 
Approximately 43% of women engaged in HIV care within 90 days of giving birth. Women who 
were retained in HIV Care prior to pregnancy were more likely to be retained during pregnancy 
(95%) and the postpartum period (76%) than women diagnosed during pregnancy or not retained 
in care prior to pregnancy.  
 
 Conclusion: Women face a myriad of challenges that make retention and viral suppression 
difficult. It is important that we utilize technology to help improve treatment received in the 
postpartum period.  
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I 
INTRODUCTION 
Background 
Advancements in medical science have significantly reduced HIV/AIDS related 
morbidity and mortality as well as perinatal HIV/AIDS infections. As a result, more HIV/AIDS 
infected women pursue motherhood. In fact approximately 8500 women living with HIV give 
birth annually (CDC, 2016b). Raising a family, particularly young infants and children place 
unique challenges on women that make adherence and retention in care much more difficult. 
This is especially dangerous because of the increased risk of morbidity and mortality associated 
with immune suppression during the postpartum period (Louis et al., 2006).  
Study Rationale & Purpose  
Rates of care retention and maintenance of viral suppression may differ by location in the 
Unites States due to the varying public health policies and infrastructure that exist in different 
states. For instance, in contrast to the low levels of postpartum retention in the first year found in 
Mississippi, 37%, (Rana et al., 2010) and in Philadelphia, 39%, (Adams et al., 2015), a study in 
the state of New York found a 70% retention rate in the first year postpartum with 50% of these 
women achieving viral suppression (Swain et al., 2016). As a result, it is imperative to determine 
the rates of retention and viral suppression as well as factors associated with these changes 
during the prenatal and postpartum period in the state of Georgia. 
The current study seeks to describe and assess rates of care engagement, retention in care, 
and viral suppression achieved by HIV infected women in Georgia during pregnancy and up to 
one year postpartum. The study will assess differences in sociodemographic factors such as 
race/ethnicity, education, number of children and age that may affect these outcome variables 
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during pregnancy and the postpartum period. We will also examine clinical variables such as 
stage of disease at delivery, adequacy of prenatal care received, and HIV care received prior to 
pregnancy (diagnosed during pregnancy, retained in care prior to pregnancy, and not retained in 
care prior to pregnancy) to determine the effects of these factors on viral suppression, care 
engagement and retention. Examination of sociodemographic and clinical variables will enable 
us to evaluate specific factors associated with achievement of viral suppression and retention 
during pregnancy and one year postpartum in the state of Georgia. We hypothesize that rates of 
retention and viral suppression will be greater during pregnancy than during the postpartum 
period as has been determined in other studies. Our aim is to get an idea of the percentage of 
HIV-infected women in Georgia who fall out of care during the postpartum period and to try to 
understand factors that may contribute to it.  
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II 
LITERATURE REVIEW 
Facts 
Approximately 1 in every 4 people living with HIV in the United States today is a 
woman. By the end of 2014, women made up 19% of the estimated new HIV diagnoses and 25% 
of the estimated AIDS diagnoses among adults and adolescents in the United States. Eighty-four 
percent of the women diagnosed with HIV in 2013 were linked to care within 3 months but only 
55% were able to be retained in care. Thirty-nine percent of women living with HIV were 
prescribed antiretroviral therapy by the end of 2012 and only 30% were able to achieve viral 
suppression (CDC, 2016a).  
HIV Care Continuum 
The goal of the HIV care continuum is to achieve viral suppression, thus increasing life 
expectancy and dramatically reducing the transmission of HIV to others. The continuum consists 
of several steps to achieve the desired outcome of viral suppression. These include HIV 
diagnosis, linkage to care, engagement and retention in care, and prescription of antiretroviral 
therapy (The HIV/AIDS Bureau, 2014). Unfortunately, many HIV infected women fail to be 
retained in care particularly during the postpartum period (Adams et al., 2015; Siddiqui et al., 
2014; Rana et al., 2010) thus increasing their risk of opportunistic infections and rapid 
advancement of disease (Bardeguez et al., 2008; Vitalis, 2013, Phillips et al., 2014). 
Socioeconomic status, race, young age, education and the challenges of coping with a new born 
have all been associated with gaps in care continuum for these women (Adams et al., 2015; 
Siddiqui et al., 2014; Rana et al., 2010; Boehme et al., 2014). A change in providers has also 
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been attributed to barriers in the care continuum for these women, particularly for those 
diagnosed during pregnancy (Turner et al., 2000).   
Adherence, Retention in Care & Viral Suppression 
 Evidence from several studies show that women are more likely to be engaged and 
retained in care during pregnancy than during the postpartum period. One study found a desire to 
stay healthy for the child and prevent mother to child transmission as the primary reason for 
adherence during pregnancy, a motivation that dissipates during the postpartum period (Mellins 
et al., 2008). As a result, viral suppression achieved during pregnancy is not maintained during 
the postpartum period. In fact, a majority of women who achieved viral suppression during 
pregnancy have been found to experience virologic rebound during the postpartum period (Sha et 
al., 2011). A New York state study also found that while 75% of women achieved viral 
suppression by delivery, only about 67% of these women were virally suppressed by their first 
VL test during the postpartum period. About 24% had rebounded to VL levels greater 1000 
copies/ml by their first postpartum test (Swain et al., 2016). HIV viral suppression is crucial not 
only for the prevention of mother to child transmission during pregnancy and delivery, it is also 
crucial to maintaining optimum health during the postpartum period. Maintaining viral 
suppression reduces the risk of HIV related morbidity, development of viral resistance to 
treatment, advancing to AIDS and reduces the risk of spreading the virus to others. 
Optimal follow-up rates with HIV care providers during the postpartum period have been 
found to be as low as 37% in the state of Mississippi (Rana et al., 2010). In that study, 18% of 
women had only one visit and 29% of women had no documented visits to an HIV care provider 
during 1 year postpartum (Rana et al.,). A South African study on loss to follow up in HIV 
positive women found that postpartum women were more likely to be lost to follow up when 
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compared to their non-pregnant counterparts. Specifically, 32% of postpartum women in their 
study became lost to follow up compared to 13% among non-pregnant individuals (Kaplan et al, 
2008). A study in Philadelphia on postpartum engagement in HIV care also found women were 
less likely to be engaged in HIV care during the postpartum period (Adams et al., 2015). 
Specifically, 92% of women were engaged in care during pregnancy compared to 38% within 90 
days of the postpartum period. They also found low rates of retention for up to 2 years in 
postpartum women (Adams et al., 2015).    
Barriers to Adherence & Retention 
 Several studies have examined barriers to adherence and retention in order to try to 
understand the significant difference in care during pregnancy and the postpartum period. The 
risk of care discontinuation has been found to be particularly high among postpartum women 
(Mellins et al., 2008) due to the challenges of caring for a newborn. A busy schedule has been 
reported as one of the barriers to adherence and retention. More specifically, many women 
reported that having a new born child disrupted their medication intake routines (Boehme et al., 
2014). A majority also reported scheduling conflicts and lack of childcare as barriers to clinic 
visits. Having multiple children was also reported as contributing to a busy schedule making it 
more difficult to attend clinic visits and take medications as prescribed (Boehme et al., 2014).  
 Other factors associated with barriers to retention and adherence includes transportation, 
clinic and copay expenses and long length of time between appointments (Boehme et al., 2014). 
Feeling depressed or overwhelmed and having other health related symptoms (Mellins et al, 
2008) as well as substance abuse and lack of self-efficacy (Vitalis, 2013) has been reported as a 
barrier to adherence. Lack of social support outside of immediate family and past experience 
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with stigma has also been identified as barriers during the postpartum period (Buchberg et al., 
2015).  
  
HIV Prenatal & Postpartum Care Retention & Viral Suppression  
Stacey Adjei 
14 
 
III 
METHODS 
Data Source 
This was a retrospective cohort study that used data collected between July 2014 and 
June of 2015 by two data sources: birth certificate records in the state of Georgia and the 
enhanced HIV/AIDS Reporting System (eHARS), both of which are managed by the Georgia 
Department of Public Health (GDPH). Georgia birth certificate records collect information 
regarding the health status as well as sociodemographic information of newborns and their 
parents. eHARS is a surveillance database that collects information an all HIV related labs 
including CD4 cell counts and viral load (VL) results.  
For this study, HIV infected women who gave birth during the study period were 
identified by the presence of a check mark in the maternal HIV infection field on Georgia birth 
certificates. These women were then matched to existing data in eHARS using the link plus 
software. After matching was complete maternal HIV laboratory data was manually extracted for 
the nine months preceding the infants date of birth and up to one year after giving birth. We also 
collected information on whether or not women had been retained in HIV care and virally 
suppressed for up to the year preceding the pregnancy period to determine if they were aware of 
their diagnosis in care or not or had been diagnosed during pregnancy.  
This study was approved by the IRBs of Georgia State University and the Georgia 
Department of Public Health. 
Study Population 
 Our study included HIV-infected women who gave birth in the state of Georgia between 
July 2014 and June 2015. Participants were excluded if there were not found in eHARS. We 
included women who did not receive care during the pregnancy or postpartum period because 
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part of our analysis focuses on rates of care retention and achievement of viral suppression 
during both periods. Including them reflects the true rates of people who fall out of care or are 
not properly reported in the state of Georgia.   
Primary Outcome 
 Five binary outcomes which include retention in care and viral suppression during both 
the pregnancy and the postpartum periods and engagement in care within 90 days of the 
postpartum period were assessed for this study. We defined retention in HIV care as having 2 or 
more laboratory tests (CD4 or Viral load test) at least 90 days apart during the pre-pregnancy (up 
to 12 months before pregnancy), pregnancy and the postpartum period (up to 12 months after 
delivery) (Office of AIDS policy, 2010). Achievement of viral suppression, defined as having a 
quantitative viral load test of 200 copies/mL or less was evaluated using the last VL test before 
or during delivery and in the 1-year pre-pregnancy and postpartum period. Postpartum care 
engagement was defined as having one or more laboratory tests (CD4 or VL test) within 90 days 
after delivery. Laboratory tests performed within 5 days of delivery were excluded because 
patients are likely to still be admitted in the hospital and not actually out seeking HIV care. 
Persons missing viral load tests were assumed to be out of care and not virally suppressed.  
Sociodemographic and Clinical Variables 
 Sociodemographic data on maternal age at delivery (18-24, 25-34, ≥35), education (< 
high school, high school graduate, some college, bachelors or higher), race/ethnicity (black, 
white, other), and parity (≤ 1, ≥ 2) were abstracted from Georgia birth certificate records. Other 
race includes Hispanic/Latino, Asian, American Indian/Alaskan Native and unknown. Clinical 
data on stage of disease at delivery (HIV, AIDS) and HIV care received (i.e. labs) before 
pregnancy were abstracted from eHARS. For HIV care received before pregnancy, women were 
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considered retained in care prior to pregnancy if they had 2 or more HIV labs that are at least 90 
days apart and virally suppressed if they had a last VL less than 200 copies/ml on record 1 year 
preceding the pregnancy period. Women without any lab records before pregnancy were 
considered to have been diagnosed during pregnancy. Number of prenatal visits was abstracted 
from Georgia birth certificate records.  The number of prenatal visits used to determine the 
adequacy of prenatal care was based on the Kessner index, a validated measure of the quality of 
prenatal care (Stringer, 1997). The Kessner index accounts for the trimester at which prenatal 
care begins, gestational age at delivery and number of prenatal visits. Adequacy was determined 
using the number of visits appropriate for 34 or more weeks because the trimester in which 
prenatal care began could not be determined from our data sources. Women missing number of 
prenatal visits were considered to have had intermediate care.   
Statistical Analysis 
 Data were analyzed in SAS 9.3. The chi-squared (X2) test was used to characterize the 
distribution of and determine differences in retention in care and achievement of viral 
suppression during the prenatal and postpartum periods. The chi-squared (X2) was also be used to 
determine the relationship between HIV care received the year prior to pregnancy and HIV care 
engagement as well as retention and viral suppression during the postpartum period. Multivariate 
logistic regression was used to determine the association between all variables (with the 
exception of number of children) and engagement in care within 90 days of the postpartum 
period. Multivariate logistic regression was also used to measure the associations between all 
variables and achievement of viral suppression and retention in care during pregnancy and the 
postpartum period with the exception of number of children. A sub analysis of the 75% of 
women for whom we had data on the number of children they had before the pregnancy under 
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study was carried out. Multivariate logistic regression examining associations between all 
variables and achievement of viral suppression, retention in care and HIV care engagement 
within 90 was carried out for this subset with the inclusion of number of children in the model. 
Statistical significance for all tests was based on a P value <0.05 using a 2 tailed test or an odds 
ratio that doesn’t include the null value of 1 in the 95% confidence interval.  
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IV 
RESULTS 
We identified 185 women with maternal HIV checked on their infant’s birth certificates for 
children born between July 2014 and June 2015. One hundred and sixty one of these women 
were successfully matched to eHARS for abstraction of lab data.  
Table 1 describes the sociodemographic and clinical variables of the participants (N= 
161) in our study. Approximately 82% of the women were non-Hispanic Black, 60% were 
between the age of 25 and 34 and 69% had a high school diploma or less. Seventy four percent 
of the women had a diagnosis of HIV before pregnancy and about 25% were diagnosed during 
pregnancy. Of those who were diagnosed before pregnancy, 57% were retained in care during 
the pre-pregnancy period. Sixty-two percent of the women received adequate prenatal care and 
50 % of women had an average of 2 children before the pregnancy under study. Forty-three 
percent of the women in our study engaged in HIV care within 90 days of the postpartum period, 
49% achieved viral suppression by the end of the postpartum period and 55% were retained in 
HIV care 1 year postpartum. 
HIV care received before pregnancy 
 Bivariate analysis comparing postpartum retention, HIV care engagement within 90 days 
and postpartum viral suppression among women diagnosed prior to pregnancy was conducted to 
examine the association between HIV care before pregnancy and postpartum retention as well as 
postpartum viral suppression. We found that women who were retained in care during the year 
before pregnancy (80.4 %) were more likely to engage in care within 90 days postpartum than 
women who were not retained in care (19.61%) X2 (1, N=120) =19.02, p <0.0001. Women who 
were retained in care before pregnancy (75.7 %) were more likely to be retained in care 
HIV Prenatal & Postpartum Care Retention & Viral Suppression  
Stacey Adjei 
19 
 
postpartum than women who were not retained before pregnancy (24.29%) X2 (1, N=120) 
=22.81, p <0.0001. Women retained before pregnancy (72.9 %) were also more likely to achieve 
viral suppression during the postpartum period than women who were not retained (27.1 %) X2 
(1, N=120) = 11.24, p=0.0008. A similar pattern was also found with achievement of viral 
suppression before pregnancy. Women who were virally suppressed during pregnancy were 
more likely engage in care within 90 days of the postpartum period (72.6% vs. 31.9% X2 (1, 
N=120) = 19.40, p<0.0001), be retained for 1 year postpartum (62.9% vs. 30.0% X2 (1, N=120) = 
12.60, p=0.0004)  and achieve viral suppression during the postpartum period (69.5% vs. 29.5% 
X2 (1, N=120) = 19.18, p<0.0001).  
A look at the rates of retention and viral suppression during the pre-pregnancy, prenatal 
and postpartum period among women diagnosed before pregnancy reveal that there is an 
increase in retention and viral suppression during the prenatal period and decrease back to pre-
pregnancy levels during the postpartum period (Figure 1). However only 80% of women who 
were retained the year before pregnancy were also retained 1 year postpartum and only 69% of 
women who achieved viral suppression one year before pregnancy achieved viral suppression 1 
year postpartum.  
Retention in Care 
 Bivariate analysis comparing the prenatal to the postpartum period showed that women 
were more likely to be retained in care during pregnancy (79.5 %) than during the postpartum 
period (55.28%), X2 (1, N=161) =10.47, p = 0.001. Retention in care during the prenatal period 
was associated with HIV care received before pregnancy and adequacy of prenatal care, in 
multivariable logistic regression (Table 2). Women who had intermediate prenatal care (60%) 
were less likely than women with adequate prenatal care (89%) to be retained during pregnancy 
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(AOR, 0.17 [95% CI, 0.07-0.46]). Women who were diagnosed during pregnancy (71%) and 
those not retained in care before pregnancy (65%) were also less likely to be retained in care 
during pregnancy than those who retained in care before pregnancy (95%) {(AOR, 0.08 [95% 
CI, 0.02-0.34]) and (AOR, 0.08 [95% CI, 0.02-0.31]) respectively}. Multivariable logistic 
regression revealed that HIV care received before pregnancy and engagement in HIV care within 
90 days were associated with postpartum retention (Table 2). Particularly, women who were 
diagnosed during pregnancy (46%) and women who were not retained in care before pregnancy 
(33%) were both less likely to be retained in postpartum care than women who were retained 1 
year before pregnancy (81%) {(AOR, 0.24 [95% CI, 0.08-0.75]) and (AOR, 0.28 [95% CI, 0.10-
0.80]) respectively}. We also found that women who engaged in care within 90 days postpartum 
(86%) were  more likely to be retained for 1 year postpartum (AOR, 14.57 [95% CI, 5.55-
38.27]). 
Viral Suppression 
 Bivariate analysis also showed that women were also more likely to achieve viral 
suppression during pregnancy (68.9 %) than during the postpartum period (49.7 %), X2 (1, 
N=161) =25.57, p <0.0001. Table 3 summarizes the results of the multivariable logistic 
regression for viral suppression during pregnancy and the postpartum period. Prenatal viral 
suppression was associated with educational attainment, maternal age and retention in care 
during the prenatal period. Particularly high school graduates (65.0 %) and those with less than a 
high school education (61.5 %) were less likely to achieve viral suppression in the prenatal 
period when compared to those who had some college education or higher (82.0%) {(AOR, 0.19 
[95% CI, 0.06-0.61]) and (AOR, 0.18 [95% CI, 0.05-0.61]0 respectively}.   Younger women, 
those between the ages of 18 and 24 (69%) and those between the ages of 25 to 34 (63%) were 
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both less likely to be virally suppressed during the prenatal period than older women, 35 years 
and older (81%) {(AOR, 0.15 [95% CI, 0.02-0.96]) and (AOR, 0.09 [95% CI, 0.02-0.52]) 
respectively}  Women who were not retained in care during the prenatal period (33%) were also 
less likely to achieve viral suppression during the prenatal period than women who were retained 
(78%) (AOR, 0.11 [95% CI, 0.03-0.35]). Achieving viral suppression during the postpartum 
period was associated viral suppression during pregnancy, retention in care during the 
postpartum period and maternal age. Women who did not achieved viral suppression (20%) 
during the prenatal period were likely to be virally suppressed during the postpartum period 
(AOR, 0.16 [95% CI, 0.05-0.48]). Women who were not retained during the postpartum period 
(22%) were also 8 times less likely to be virally suppressed at one year (AOR, 0.12 [95% CI, 
0.06-0.49]). We found that women between the ages of 25 and 34 (52%) were more likely to 
achieve viral suppression during the postpartum period than those between 18 and 24 (36%) 
years of age (AOR, 3.03 [95% CI, 1.05-8.76]). 
Postpartum Care Engagement 
 Postpartum care engagement in our study population was low, approximately 43% of 
women engaged in HIV care within 90 days of giving birth. We found that HIV care received 
before pregnancy was associated with care engagement within 90 days. Specifically, women who 
were retained in care the year prior to their pregnancy were more likely to be engaged in HIV 
care within 90 days of the postpartum period than women who were not in care the year prior to 
pregnancy (AOR, 7.02 [95% CI, 2.68-18.42]). Women who were diagnosed during pregnancy 
were also more likely to be retained in postpartum care than women who were not retained in 
care 1 year prior to pregnancy (AOR, 4.34 [95% CI, 1.54-12.27]). Achievement of viral 
suppression during pregnancy was also found to be associated with engaging in care within 90 
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days after giving birth. Women who were not virally suppressed by the end of their pregnancy 
were less likely to engage in HIV care within 90 days of giving birth (AOR, 0.27 [95% CI, 0.08-
0.58]).  
A second multivariate analysis was performed to determine whether engagement during the 
first 90 days of the postpartum period is associated with retention in care and viral suppression. We 
found that when race, education, and age are accounted for, care engagement within 90 days of 
the postpartum period is predictive of retention in care (AOR, 14.76 [95% CI, 6.34-34.39] p 
<0.0001) and achievement of viral suppression (AOR, 6.52 [95% CI, 3.19-13.35] p<0.0001) 
during the postpartum period.  Specifically, women were more likely to achieve viral 
suppression and be retained in care 1 year postpartum if they engaged in HIV care within 90 
days of the postpartum period. 
Sub analysis with number of children 
 The multivariate sub analysis including number of children in each of the models for a 
subset of the women (75%, N=122) was conducted to examine the effects of including number of 
previous children on retention, care engagement and viral suppression. Previous number of 
children was not found to be significantly associated with any of the outcome variables. We 
found that including previous number of children did not change the variables that were 
significantly associated with care engagement within 90 days, retention and viral suppression. 
Tables five through seven summarizes our findings of factors associated with retention, viral 
suppression and postpartum engagement when previous number of children is included in the 
model. 
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V 
 DISCUSSION 
As expected we found that women in Georgia are more likely to be retained in care and 
achieve viral suppression during pregnancy than during the postpartum period. This finding is 
consistent with previous studies (Adams et al., 2015; Rana et al., 2010; Onen et al., 2008) and 
highlights the importance of linkage to care to an HIV care provider outside the obstetrics field 
for these women. It may be important for linkage to a non-obstetrics HIV provider to occur 
during the pregnancy period to allow for optimum engagement in care during the postpartum 
period as a change in providers may contribute to delays in care engagement (Turner et al., 2000) 
due to lack of familiarity. Our study found women who engaged in HIV care within 90 days of 
the postpartum period were more likely to be retained and to be virally suppressed 1 year 
postpartum. Early linkage to care to a non-obstetric HIV care provider particularly for women 
diagnosed during pregnancy may contribute long-term retention and viral suppression.  
Our study found that women were more likely to achieve viral suppression during the 
postpartum period if they were virally suppressed during pregnancy. This finding emphasizes the 
importance of education on adherence to medication and care during the pregnancy period where 
good adherence habits are likely to be formed. Cavallo et al., 2010 found that women with poor 
adherence to ART during pregnancy (which predicts low likelihood of viral suppression) are less 
likely to be adherent postpartum. To increase rates of viral suppression in the postpartum period, 
it may be important for healthcare providers to educate women on the importance of continued 
adherence during the postpartum period. We also found that women were likely to achieve viral 
suppression postpartum if they were retained in care in the postpartum period. Retention in care 
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is likely to lead to higher adherence rates and thus contribute to achieving viral suppression 
during the postpartum period. 
 To our knowledge, our study is the first to examine the relationship between pre-
pregnancy HIV care and postpartum retention and viral suppression. We found that care received 
prior to pregnancy was the most consistent factor associated with postpartum retention and 
engagement in care within 90 days. Women who were retained in care before pregnancy were 
more likely to engage in care within 90 days of giving birth and to be retained during the 
postpartum period than women who were diagnosed during pregnancy and women who were not 
retained in care before pregnancy. Bivariate analysis looking at just women who were diagnosed 
before pregnancy shows that those retained in care were more likely to be engaged in care with 
90 days, be retained 1 year postpartum and achieve viral suppression than women who were not 
retained before pregnancy. We found pre-pregnancy rates of retention and viral suppression to be 
similar to rates of retention and viral suppression during the postpartum period. This finding 
suggests that women may not just be falling out of care during the postpartum period but simply 
returning to their pre-pregnancy care pattern. If so, it may be important to educate women on the 
importance of adherence to HIV care to their overall health and wellbeing and that of their 
families, for instance in prevention of HIV/AIDS related orphaning. However, we also found that 
only about 80% of women who were retained before pregnancy are also retained postpartum and 
only about 70% of women who achieve viral suppression pre-pregnancy were also virally 
suppressed during the postpartum period. This finding reflects findings from previous studies 
about the unique challenges during the postpartum period such having to care for a newborn 
(Boehme et al., 2014) and lack of social support (Buchberg et al., 2015) that may contribute to 
failure to be retained in care and achieve viral suppression. 
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Our sub analysis that included number of children in the model did not cause significant 
changes to our results. However including it in the models emphasized the importance of 
postpartum viral suppression and care engagement within 90 days on postpartum retention. It 
also emphasized the importance of HIV care before pregnancy on early care engagement and 
postpartum viral suppression and retention. Boehme et al., 2014 found that having multiple 
children made it difficult for women to attend clinic visits. A larger sample may be able to 
properly detect the true effects of having multiple children on postpartum viral suppression.  
There are several limitations to our study. First of all, we relied on surveillance records 
which are dependent on the quality and completeness of the records reviewed.  We were 
therefore unable to collect information of insurance status and social support which may play a 
role in retention in care and achievement of viral suppression. We used HIV viral load and CD4 
count labs as proxy for medical visits because studies based on chart abstraction have shown a 
high correlation between medical visits and lab reports (CDC, 2014). However, retention could 
be under-ascertained if laboratory reporting is incomplete  
Our study highlights the importance of establishing quality HIV care throughout the life 
span of a woman. Sustained HIV care engagement should be made a priority because it predicts 
long term retention and continued viral suppression. Women who are diagnosed during 
pregnancy, those who are unable to achieve viral suppression during pregnancy and those who 
receive inadequate HIV care before pregnancy should be considered as high risk for not 
engaging in early postpartum care or being retained postpartum. These women may benefit from 
strong interventions to overcome barriers to care during pregnancy than any other time because 
they are likely to be motivated to stay in care during that period.  
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Barriers to care during the postpartum period may be overcome by ensuring that women 
who need a different HIV provider after delivery are linked to one while still pregnant. For these 
women, we recommend that linkage occur by providing them assistance with making an 
appointment within 90 days of the postpartum period with their new HIV provider. We also 
recommend case management for HIV infected pregnancy women so they may be better retained 
during the pregnancy and postpartum periods to reduce harm associated with non-adherence and 
failure to attend necessary clinic appointments. Case managers may be more aware of the unique 
challenges each individual woman faces and thus be better able to provide the support needed for 
continued care during the postpartum period.  
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Table 1. Demographic and Clinical Variables of Cases.  
 
                                                                                       Total Study Population 
                                                                                              (N=161 ) 
Characteristics                                                          No.                                      % 
Race/Ethnicity   
    Black 
    White 
    Other 
133  
16 
12 
82.61 
9.94 
7.45 
Maternal age at delivery   
    18-24 
    25-34 
    ≥35 
39 
98 
24 
24.22 
60.87 
14.91 
Education   
    < High school 
    High school graduate 
    ≥Some college education 
52 
60 
49 
32.30 
37.27 
30.43 
HIV care received before Pregnancy   
    Diagnosed during pregnancy 
    Retained in care before pregnancy 
    Not retained in care before pregnancy 
41 
69 
51 
25.47 
42.86 
31.68 
Stage of disease at delivery   
    HIV 
    AIDS 
117 
44 
72.67 
27.33 
Adequacy of prenatal care   
    Adequate 
    Intermediate 
    Inadequate 
100 
48 
13 
62.11 
28.81 
8.07 
Parity   
    ≤ 1 child 
    ≥ 2 children 
42 
80 
26.09 
49.69 
Retention   
    Retained during pregnancy 
    Retained postpartum 
128 
89 
79.50 
55.28 
Viral Suppression   
    Achieved prenatal Viral Suppression 
    Achieved postpartum Viral Suppression 
111 
80 
68.94 
49.69 
Engaged in care within 90 days 70 43.48 
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Table 2. Factors Associated with Retention in HIV Care during Pregnancy and the 
Postpartum Period in Multivariable Logistic Regression Models.  
 
 CHARACTERISTICS                                Prenatal retention                 Postpartum retention  
                                                                   %          AOR       CI                %        AOR          CI                                                                             
Race/Ethnicity       
   Black 
   White 
   Other 
78.95 
81.25 
83.33 
0.92 
1 
1.70 
0.17-4.85 
NA 
0.16-18.60 
53.38 
50.00 
83.33 
2.25 
1 
26.77 
0.43-11.76 
NA 
2.03-353.2 
Maternal age at delivery       
   18-24 
   25-34 
   ≥35 
87.18 
76.53 
79.17 
3.11 
1 
1.15 
0.84-11.52 
NA 
0.31-4.28 
53.85 
56.12 
54.17 
1.60 
1 
0.72 
0.54-4.75 
NA 
0.21-2.41 
Education       
   <High school 
   High school graduate 
   ≥Some college 
76.92 
85.00 
75.51 
0.41 
1 
0.46 
0.13-1.31 
NA 
0.14-1.50 
55.77 
53.33 
57.14 
0.88 
0.76 
1 
0.28-2.83 
0.27-2.17 
NA 
HIV care before pregnancy       
  Dx during pregnancy 
  Retained in care before pregnancy 
Not retained in care before pregnancy 
70.73
95.65 
64.71 
0.08 
1 
0.08 
0.02-0.34 
NA 
0.02-0.31 
46.34 
76.81
33.33 
0.24 
1 
0.28 
0.08-0.75 
NA 
0.10-0.80 
Stage of disease at delivery       
   HIV  
   AIDS 
81.20 
75.00 
1.55 
1 
0.55-4.23 
NA 
53.85 
59.09 
0.75 
1 
0.28-2.03 
NA 
Adequacy of prenatal care       
   Adequate 
   Intermediate 
   Inadequate  
89.00 
60.42 
76.92 
1 
0.17 
0.22 
NA 
0.07-0.46 
0.04-1.14 
65.00 
37.50 
46.15 
1 
0.40 
0.50 
NA 
0.15-1.17 
0.10-2.41 
Care engagement within 90 days       
   Engaged 
   Not engaged 
NA 
NA 
NA 
NA 
NA 
NA 
85.71 
31.87 
14.57 
1 
5.55-38.27 
NA 
Retained during pregnancy       
   Retained  
   Not retained 
NA 
NA 
NA 
NA 
NA 
NA 
61.72 
30.30 
1 
0.41 
NA 
0.12-1.39 
Abbreviations: AOR, adjusted odds ratio; CI, confidence interval; HIV human immunodeficiency virus; AIDS, 
acquired immune deficiency syndrome; Dx, diagnosis; NA, not applicable;  
Confidence intervals that don’t overlap the null value of 1 are shown in bold. Multivariate logistic regression for 
each outcome included all of the demographic and clinical variables listed in the table. 
 
 
 
HIV Prenatal & Postpartum Care Retention & Viral Suppression  
Stacey Adjei 
31 
 
Table 3. Factors Associated with Viral Suppression during Pregnancy and the Postpartum 
Period in Multivariable Logistic Regression Models.  
 
                                                       Prenatal Viral Suppression      Postpartum Viral Suppression   
Characteristics                                       %        AOR         95%CI          %        AOR           95%CI            
Race/Ethnicity       
   Black 
   White 
   Other 
66.92 
75.00 
83.33 
0.35 
1 
1.94 
0.08-1.52 
NA 
0.22-17.36 
48.87 
43.75 
66.67 
1.80 
1 
1.90 
0.40-8.02 
NA 
0.24-15.23 
Maternal age at delivery       
   18-24 
   25-34 
   ≥35 
69.23 
63.27 
91.67 
0.15 
0.09 
1 
0.02-0.96 
0.02-0.52 
NA 
35.90 
52.04 
62.50 
1 
3.03 
2.61 
NA 
1.05-8.76 
0.62-11.09 
Education       
   <High school 
   High school graduate 
   ≥Some college 
61.54 
65.00 
81.63 
0.18 
0.19 
1 
0.05-0.61 
0.06-0.61 
NA 
46.15 
46.67 
57.14 
0.98 
0.69 
1 
0.30-3.18 
0.24-2.00 
NA 
HIV care before pregnancy       
   Dx during pregnancy 
   Retained before pregnancy 
   Not retained before pregnancy* 
68.29 
79.71 
54.90 
2.196 
2.08 
1 
0.76-6.37 
0.76-5.66 
NA 
51.22 
62.32 
31.37 
2.42 
1.14 
1 
0.72-8.16 
0.39-3.34 
NA 
Stage of disease at delivery       
   HIV 
  AIDS 
70.09 
65.91 
1.11 
1 
0.43-2.86 
NA 
45.30 
61.36 
0.41 
1 
0.15-1.13 
NA 
Adequacy of prenatal care       
   Adequate 
   Intermediate 
   Inadequate 
76.00 
58.33 
53.85 
1 
0.69 
0.45 
NA 
0.27-1.75 
0.11-1.89 
58.00 
31.25 
53.85 
1 
0.49 
1.96 
NA 
0.18-1.32 
0.38-10.11 
Prenatal retention in care       
   Retained 
   Not retained 
78.13 
33.33 
1 
0.11 
NA 
0.03-0.35 
54.69 
30.30 
1 
1.06 
NA 
0.28-3.94 
Postpartum retention in care       
   Retained 
   Not retained 
NA 
NA 
NA 
NA 
NA 
NA 
71.91 
22.22 
1 
0.12 
NA 
0.06-0.49 
Prenatal viral suppression       
   Suppressed 
   Not suppressed 
NA 
NA 
NA 
NA 
NA 
NA 
63.06 
20 
1 
0.16 
NA 
0.05-0.48 
Care engagement within 90 days       
   Engaged 
   Not engaged 
NA 
NA 
NA 
NA 
NA 
NA 
74.29 
30.77 
1 
0.42 
NA 
0.16-1.08 
Abbreviations: AOR, adjusted odds ratio; CI, confidence interval; HIV human immunodeficiency virus; AIDS, 
acquired immune deficiency syndrome; Dx, diagnosis; NA, not applicable;  
Confidence intervals that don’t overlap the null value of 1 are shown in bold. Multivariate logistic regression for 
each outcome included all of the demographic and clinical variables listed in the table. 
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Table 4. Factors that Predict HIV Care Engagement within 90 days of 
the Postpartum Period in Multivariable Logistic Regression Models.  
       
Characteristics                                       %               AOR                  95%CI                      
Race/Ethnicity    
   Black 
   White 
   Other 
42.11 
50.00 
50.00 
0.90 
1 
0.97 
0.27-2.96 
NA 
0.18-5.25 
Maternal age at delivery    
    18-24 
   25-34 
   ≥35 
35.90 
44.90 
50.00 
1 
1.53 
0.77 
NA 
0.60-3.88 
0.26-2.26 
Education    
   <High school 
   High school 
   ≥Some college 
40.38 
43.33 
46.94 
0.69 
1 
0.86 
0.28-1.74 
NA 
0.34-2.20 
Stage of disease at delivery    
   HIV 
   AIDS 
41.03 0.62 
1 
0.27-1.42 
NA 50.00 
HIV care before pregnancy    
   Dx during pregnancy 
   Retained before pregnancy 
   Not retained before pregnancy 
46.34 
53.85 
6.90 
4.34 
7.02 
1 
1.54-12.27 
2.68-18.42 
NA 
Adequacy of prenatal care    
   Adequate 
   Intermediate 
   Inadequate 
49.00 
33.33 
38.46 
1 
0.50 
0.54 
NA 
0.21-1.19 
0.13-4.92 
Stage of disease at delivery    
  HIV 
   AIDS 
41.03 
50.00 
0.62 
1 
0.27-1.42 
NA 
Prenatal Viral Suppression    
   Suppressed 
   Not suppressed 
52.25 
24.00 
1 
0.27 
NA 
0.08-0.58 
Prenatal retention in care    
   Retained 
   Not retained 
45.31 
54.69 
1 
2.79 
NA 
0.89-8.73 
Abbreviations: AOR, adjusted odds ratio; CI, confidence interval; HIV human 
immunodeficiency virus; AIDS, acquired immune deficiency syndrome; Dx, diagnosis; 
NA, not applicable;  
Confidence intervals that don’t overlap the null value of 1 are shown in bold. 
Multivariate logistic regression for each outcome included all of the demographic and 
clinical variables listed in the table. 
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Table 5. Factors Associated with Retention in HIV Care during Pregnancy and during the 
Postpartum Period in Multivariable Logistic Regression Models when Number of Children 
are Included.  
 
 CHARACTERISTICS                                Prenatal retention                 Postpartum retention  
                                                                   %          AOR       CI                %        AOR          CI                                                                             
Race/Ethnicity       
  Black 
   White 
   Other 
79.21 
83.33 
88.89 
0.40 
1 
2.0 
0.03-4.84 
NA 
0.10-5.87 
46.53 
58.33 
88.89 
1.39 
1 
21.80 
0.19-10.11 
NA 
0.97-489.3 
Maternal age at delivery       
   18-24 
   25-34 
   ≥35 
86.36 
78.21 
81.82 
1.70 
1 
1.01 
0.29-9.91 
NA 
0.24-4.37 
50.00 
51.28
50.00 
1.14 
1 
0.63 
0.28-4.73 
NA 
0.15-2.71 
Education       
   <High school 
   High school graduate 
   ≥Some college 
78.57 
86.36 
75.00 
0.45 
1 
0.42 
0.12-1.72 
NA 
0.11-1.67 
54.76 
52.27 
44.44 
0.86 
1 
0.76 
0.23-3.26 
NA 
0.21-2.74 
HIV care before pregnancy       
  Dx during pregnancy 
  Retained during pregnancy 
  Not retained during pregnancy 
72.00
94.74
65.00 
0.11 
1 
0.12 
0.02-0.55 
NA 
0.03-0.49 
40.00 
75.44 
22.50 
0.27 
1 
0.20 
0.07-1.09 
NA 
0.06-0.68 
Stage of disease at delivery       
   HIV  
   AIDS 
81.40 
77.78 
1.23 
1 
0.40-3.81 
NA 
48.84 
55.56 
0.62 
1 
0.19-2.01 
NA 
Adequacy of prenatal care       
   Adequate 
   Intermediate 
   Inadequate 
89.47 
63.89 
70.00 
1 
0.31 
0.17 
NA 
0.10-0.95 
0.03-1.02 
60.53 
36.11 
30.00 
1 
0.39 
0.34 
NA 
0.12-1.30 
0.04-2.61 
Number of Children       
  >1 
   ≤1 
75.00 
90.48 
0.30 
1 
0.07-1.23 
NA 
51.25 
50.00 
1.61 
1 
0.52-4.95 
NA 
Care engagement within 90 days       
   Engaged 
   Not engaged 
NA 
NA 
NA 
NA 
NA 
NA 
82.35 
28.17 
12.50 
1 
4.06-38.45 
NA 
Retained during pregnancy       
   Retained  
   Not retained 
NA 
NA 
NA 
NA 
NA 
NA 
58.16 
20.83 
1 
0.05 
NA 
0.05-1.21 
Abbreviations: AOR, adjusted odds ratio; CI, confidence interval; HIV human immunodeficiency virus; AIDS, 
acquired immune deficiency syndrome; Dx, diagnosis; NA, not applicable;  
Confidence intervals that don’t overlap the null value of 1 are shown in bold. Multivariate logistic regression for 
each outcome included all of the demographic and clinical variables listed in the table. 
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Table 6. Factors Associated with Viral Suppression during Pregnancy and during the 
Postpartum Period when number of children is included in Multivariable Logistic 
Regression Models.  
 
                                                       Prenatal Viral Suppression      Postpartum Viral Suppression   
Characteristics                                       %        AOR         95%CI          %        AOR           95%CI            
Race/Ethnicity       
   Black 
   White 
   Other 
65.35 
66.67 
88.89 
0.46 
1 
4.09 
0.10-2.19 
NA 
0.28-59.73 
46.53 
50.00 
77.78 
1.51 
1 
1.74 
0.30-7.69 
NA 
0.15-19.70 
Maternal age at delivery       
   18-24 
   25-34 
   ≥35 
68.18 
60.26 
90.91 
0.22 
0.10 
1 
0.03-1.53 
0.02-0.55 
NA 
40.91 
48.72 
59.09 
1 
2.45 
1.91 
NA 
0.59-10.13 
0.35-10.54 
Education       
   <High school 
   High school graduate 
   ≥Some college 
59.52 
65.91 
77.78 
0.23 
0.28 
1 
0.06-0.87 
0.08-1.02 
NA 
50.00 
47.73 
50.00 
0.98 
0.73 
1 
0.24-3.90 
0.22-2.45 
NA 
HIV care before pregnancy       
   Dx during pregnancy 
   Retained before pregnancy 
   Not retained before pregnancy* 
68.00 
75.44 
55.00 
1.35 
1.44 
1 
0.35-5.19 
0.48-4.32 
NA 
48.00 
63.16 
30.00 
2.26 
1.23 
1 
0.47-11.02 
0.34-4.39 
NA 
Stage of disease at delivery       
   HIV 
  AIDS 
69.77 
61.11 
1.38 
1 
0.50-3.83 
NA 
45.35 
58.33 
0.43 
1 
0.14-1.31 
NA 
Adequacy of prenatal care       
   Adequate 
   Intermediate 
   Inadequate 
73.68 
61.11 
40.00 
1 
0.92 
0.27 
NA 
0.31-2.73 
0.05-1.45 
56.58 
33.33 
50.00 
1 
0.47 
2.76 
NA 
0.15-1.48 
0.46-16.51 
Prenatal retention in care       
   Retained 
   Not retained 
75.51 
33.33 
1 
0.15 
NA 
0.04-0.54 
54.08 
29.17 
1 
1.29 
NA 
0.31-5.43 
Number of Children       
   >1 
   ≤1 
62.50 
76.19 
0.62 
1 
0.22-1.76 
NA 
47.50 
52.38 
1.26 
1 
0.43-3.73 
NA 
Postpartum retention in care       
   Retained 
   Not retained 
NA 
NA 
NA 
NA 
NA 
NA 
74.19 
23.33 
1 
0.12 
NA 
0.03-0.48 
Prenatal viral suppression       
   Suppressed 
   Not suppressed 
NA 
NA 
NA 
NA 
NA 
NA 
62.20 
22.50 
1 
0.14 
NA 
0.05-0.48 
Care engagement within 90 days       
   Engaged 
   Not engaged 
NA 
NA 
NA 
NA 
NA 
NA 
70.59 
33.80 
1 
0.68 
NA 
0.22-2.06 
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Abbreviations: AOR, adjusted odds ratio; CI, confidence interval; HIV human immunodeficiency virus; AIDS, 
acquired immune deficiency syndrome; Dx, diagnosis; NA, not applicable;  
Confidence intervals that don’t overlap the null value of 1 are shown in bold. Multivariate logistic regression for 
each outcome included all of the demographic and clinical variables listed in the table. 
 
Table 7. Factors that Predict HIV Care Engagement within the first 
90 days of the Postpartum Period when children are included when 
number of children is included in Multivariable Logistic Regression 
Models.  
       
Characteristics                                       %               AOR                  95%CI                      
Race/Ethnicity    
   Black 
   White 
   Other 
38.61 
58.33 
55.56 
0.58 
1 
0.57 
0.14-2.41 
NA 
0.07-4.53 
Maternal age at delivery    
    18-24 
   25-34 
   ≥35 
36.36 
42.31 
45.45 
1 
2.24 
1.21 
NA 
0.63-8.01 
0.26-5.65 
Education    
   <High school 
   High school 
   ≥Some college 
42.86 
43.18 
38.89 
0.75 
1 
0.62 
0.24-2.33 
NA 
0.20-1.88 
Stage of disease at delivery    
   HIV 
   AIDS 
40.70 0.71 
1 
0.27-1.84 
NA 44.44 
HIV care before pregnancy    
   Dx during pregnancy 
   Retained before pregnancy 
   Not retained before pregnancy 
44.00 
59.65 
15.00 
7.06 
11.21 
1 
1.71-29.22 
3.44-36.54 
NA 
Number of children    
   >1 
   ≤1 
41.25 
42.86 
1.32 
1 
0.49-3.53 
NA 
Adequacy of prenatal care    
   Adequate 
   Intermediate 
   Inadequate 
46.05 
36.11 
30.00 
1 
0.77 
0.65 
NA 
0.28-2.14 
0.12-3.52 
Prenatal Viral Suppression    
   Suppressed 
   Not suppressed 
50.00 
25.00 
1 
0.25 
NA 
0.08-0.79 
Prenatal retention in care    
   Retained 
   Not retained 
43.88 
33.33 
1 
2.54 
NA 
0.69-9.34 
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Abbreviations: AOR, adjusted odds ratio; CI, confidence interval; HIV human 
immunodeficiency virus; AIDS, acquired immune deficiency syndrome; Dx, diagnosis; 
NA, not applicable;  
Confidence intervals that don’t overlap the null value of 1 are shown in bold. 
Multivariate logistic regression for each outcome included all of the demographic and 
clinical variables listed in the table. 
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Figure 1. Rate comparison between pre-pregnancy, prenatal and 
postpartum period.
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